Os melhores médicos para o tratamento de Cancro do pâncreas no exterior — Página 5

O Dr. Erkan Göcen é especialista em Oncologia Radioterápica no Hospital Privado Çerkezköy Optimed (Optimed Health Group). Formou-se na Universidade de Istambul, Faculdade de Medicina (Çapa), em 2003.

Carreira: Treinou e praticou em Oncologia Radioterápica de 2010 a 2012. Trabalhou em instituições de saúde públicas e privadas de 2012 a 2016. Trabalhou no setor médico privado como especialista em Oncologia Radioterápica de 2016 a 2023. Está no Hospital Optimed desde 2024.

Interesses clínicos: cânceres de cérebro, cabeça e pescoço, esôfago, estômago, colorretal, pâncreas, próstata, bexiga, pulmão, tecidos moles (sarcomas), pele, útero e colo do útero, e mama. Afiliações: Sociedade Turca de Oncologia Radioterápica (TROD) e Câmara Médica de Tekirdağ. Idiomas: inglês e turco.

O Dr. Kim Taekhyeon é cirurgião gastrointestinal e Chefe de Cirurgia Gastrointestinal no Hospital Naeun. Ele recebeu seu diploma de médico e mestrado na Faculdade de Medicina da Universidade Chung-Ang. Concluiu um estágio no Hospital Sungae e uma residência em cirurgia geral no Hospital da Universidade Chung-Ang. Em seguida, terminou uma especialização em cirurgia gastrointestinal no Hospital St. Mary de Seul. Anteriormente, atuou como cirurgião assistente no Hospital Gwangmyeong Sungae.

Sua pesquisa abrange a survivina e a HSP90 no câncer colorretal, segundos cânceres primários em pacientes com câncer gástrico e carcinoma gástrico tipo IV de Borrmann. Ele relatou os resultados da reparação laparoscópica de hérnia inguinal totalmente extraperitoneal em 92 casos. Sua prática clínica inclui cânceres e doenças do estômago, esôfago e intestino delgado. Ele também trata hérnias, cálculos biliares e colecistite, apendicite, doenças anais, varizes e queimaduras.

O Prof. Dr. Abdullah Sakin é professor de oncologia médica. Trata tumores sólidos, incluindo cancro do pulmão, mama, gastrointestinal, geniturinário, ginecológico, de cabeça e pescoço, e melanoma.

Oferece cuidados personalizados baseados em evidências. Os seus tratamentos incluem quimioterapia, terapia direcionada, imunoterapia, terapia hormonal e oncologia de precisão. É autor de mais de 200 publicações científicas e participa em investigação clínica internacional. Este trabalho promove cuidados oncológicos centrados no paciente.

A Prof. Dra. Gül Alço é oncologista radioterapeuta com cerca de 27 anos de experiência. Trata cancros da mama, pulmão, próstata, gastrointestinais, ginecológicos, do sistema nervoso central, cabeça e pescoço, tecidos moles e ósseos com radioterapia.

A sua experiência inclui radioterapia adaptativa e radiocirurgia. Utiliza técnicas de radiação avançadas para prestar cuidados personalizados e baseados em evidências num ambiente multidisciplinar centrado no paciente.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

O Professor Lim Do Hoon lidera o Departamento de Oncologia Radioterápica no Samsung Medical Center, especializando-se em câncer pancreatobiliar.

• Formado na Faculdade de Medicina da Universidade Nacional de Seul
• Treinamento especializado no Samsung Medical Center e no Hospital da Universidade Nacional de Seul
• Especialista em cânceres de estômago e pancreatobiliares
• Também trata tumores do SNC, tumores pediátricos, sarcomas e cânceres hematológicos

O Dr. Dong Wook Choi é especializado em câncer de pâncreas no Samsung Medical Center, com formação nas principais instituições dos EUA e do Japão.

• Bolsa de pesquisa na Universidade de Pittsburgh, líder em oncologia cirúrgica
• Membro da Associação Internacional de Cirurgia Hepato-Biliar-Pancreática
• Ativo no Korean Pancreas Surgery Club
• Residência e estágio no Hospital da Universidade Nacional de Seul

O Dr. Antonio de Lacy Fortuny realizou mais de 15.000 procedimentos cirúrgicos, sendo pioneiro em técnicas minimamente invasivas a nível mundial.

• Especializar-se em cirurgias gastrointestinais, incluindo tratamentos de cancro do pâncreas
• Realizar mais de 1.000 procedimentos minimamente invasivos anualmente
• Presidente da Associação de Cirurgiões Endoscopistas da Europa
• Pioneiro da técnica TaTME para o cancro retal

A Dra. Leng Yin especializa-se em oncologia pancreática no Fuda Cancer Hospital e possui experiência nos melhores hospitais da Tailândia e da China.

• Especialista em oncologia do fígado, vesícula biliar, estômago, pâncreas e trato intestinal
• Trabalhou no Bumrungrad International Hospital e no Royal Siriraj Hospital
• Membro da Associação Chinesa de Combate ao Câncer

O Professor Kyu Taek Lee é especializado em cânceres de pâncreas, ductos biliares e vesícula biliar no Samsung Medical Center.

• Especialista em gastroenterologia no Samsung Medical Center
• Formado na Stanford University School of Medicine
• Membro da Sociedade Coreana de Endoscopia Gastrointestinal

O Prof. Jong Kyun Lee está entre os melhores gastroenterologistas da Coreia do Sul e da Ásia, especializado em cânceres de pâncreas, ductos biliares e vesícula biliar.

• Gastroenterologista no Samsung Medical Center
• Formado na Universidade Nacional de Seul e na Universidade da Califórnia
• Membro da Sociedade Coreana de Endoscopia Gastrointestinal e da Associação Coreana de Pâncreas e Vias Biliares

O Dr. Gutman é especializado em cirurgia de cancro do pâncreas no Centro Médico Assuta, o principal hospital privado de Israel.

• Cirurgião oncológico com vasta experiência em casos complexos de cancro
• Trabalha numa unidade médica de topo com tecnologia avançada
• Foca-se exclusivamente em tratamentos de oncologia cirúrgica

O Professor Yoram Kluger especializa-se em oncocirurgia no Rambam Medical Center, focando-se em casos de cancro do pâncreas.

• Professor com vasta experiência cirúrgica em oncologia
• Trabalha no Rambam Medical Center, um prestador de cuidados de saúde de referência
• Especializado em procedimentos complexos de remoção de tumores

Tamar Jablonski-Perec completou um estágio fundamental em oncologia no renomado Sloan-Kettering Cancer Center em Nova York.

• Chefe do Instituto de Oncologia do Centro Médico Hadassah
• Liderou o Centro de Tratamento de Câncer de Mama e é professora de oncologia
• Doutora em Ciências Médicas pela Universidade Hebraica de Jerusalém
• Membro de várias sociedades internacionais de câncer
• Bolsista da Escola de Medicina Hadassah

Especialista em cirurgia de câncer de pâncreas nos hospitais Büyük Anadolu, com foco em procedimentos oncológicos complexos.

• Especialista em cirurgias de câncer de pâncreas, vias biliares e estômago
• Realiza cirurgias oncológicas e metabólicas bariátricas avançadas
• Habilidoso em técnicas minimamente invasivas para o tratamento do câncer

Radioterapeuta no Assuta Medical Center, especializado no tratamento do cancro do pâncreas.

• Foca-se na radioterapia direcionada para tumores pancreáticos
• Trabalha no Assuta Medical Center, uma instalação oncológica líder
• Especializado em técnicas de radiação de precisão para casos complexos

Mais de 3.600 cirurgias de pâncreas realizadas – O Prof. Falconi especializa-se em técnicas de preservação de órgãos no Hospital San Raffaele.

• _doctor_1724_anos_ de experiência em oncologia gastrointestinal
• Diretor de Cirurgia Pancreática no IRCCS Ospedale San Raffaele
• Formado nos melhores hospitais internacionais no Japão, Espanha, Alemanha e Suécia
• Publicou mais de 330 artigos sobre tratamentos pancreáticos
• Membro de 5 grandes sociedades pancreáticas internacionais